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Abstract  20 
Wild copepods are the main natural diet of marine finfish and they meet the larvae’s 21 
requirements in phospholipids and essential fatty acids (EFA). While Artemia nauplii are an 22 
easier and more reliable live feed to produce in hatcheries for marine fish larvae than wild 23 
zooplankton, enrichment products commercially used lack phospholipids and essential long-24 
chain polyunsaturated fatty acids (LC-PUFA). This is particularly true for docosahexaenoic 25 
acid (DHA) within their polar lipid fraction (PLDHA), which is critical to the survival and good 26 
development of the larvae. In this study, we showed that it is possible to increase the levels of 27 
phospholipids and DHA within the PL fraction of Artemia nauplii using marine lecithin through 28 
a process referred to as “boosting”. A cheaper alternative to marine lecithin, soya lecithin, was 29 
also tested but resulted only in a significant increase of the phospholipid content of the nauplii 30 
with no positive effect on the essential LC-PUFA levels, due to the absence of LC-PUFA in 31 
the soya lecithin. This study also showed that the levels of PLDHA in the Artemia boosted with 32 
marine lecithin did not reflect the levels of PLDHA in the lecithin, highlighting there the 33 
complexity of the boosting process. Finally, chilling enriched Artemia nauplii at 5 ºC for up to 34 
10 h did not impact on their nutritional quality post-enrichment. Ultimately, this study proposes 35 
innovative and sound enrichment strategies to produce Artemia nauplii rich in EFA and/or PL, 36 
similarly to that of the wild copepods’ lipid profile. 37 
Keywords: Artemia, DHA, enrichment, lecithin, polar lipids.  38 
 39 
Introduction  40 
The emergence of new marine fish species in aquaculture is leading to an increase in the 41 
demand for high quality fish larvae. The production of marine fish larvae is generally hampered 42 
by low survival, poor growth and high occurrence of deformities (Hamre et al., 2013; Holt, 43 
2011). The underlying causes of poor performance in marine fish larvae is multifactorial, 44 
however nutrition plays a critical role to ensure normal development of fish larvae (Hamre et 45 
al., 2013; Rønnestad et al., 2013). Even though considerable progress has been made on the 46 
formulation of artificial larval feeds, most marine hatcheries still rely on the production of live 47 
preys used to feed larval stages of marine fish (Conceição et al., 2010). Among those live preys, 48 
wild copepods are the natural diet of marine fish larvae (Hunter, 1980) and they exhibit optimal 49 
nutritional profiles (Ajiboye et al., 2011; van der Meeren et al., 2008; Støttrup, 2000). However, 50 
wild copepods are rarely used in hatcheries as the production is highly seasonal, lacks reliability 51 
and presents an elevated risk of introducing pathogens into the hatchery systems (Støttrup, 52 
2000). Although farmed copepods constitute an alternative to their wild counterparts, they are 53 
challenging to produce, and the limited supply of high-quality cysts cannot meet the demand 54 
of the rapidly expanding marine finfish hatcheries. Therefore, the traditional use of live preys 55 
including rotifers and Artemia nauplii remains the most common choice to feed larval stages 56 
of any established marine finfish species such as Atlantic cod Gadus morhua (Hamre et al., 57 
2008; Rocha et al., 2017) and Atlantic halibut Hippoglossus hippoglossus (Evjemo et al., 2003) 58 
as well as new emerging species like Amberjack Seriola dumerili (Papandroulakis et al., 2005; 59 
Yamamoto et al., 2008) and ballan wrasse Labrus bergylta (Øie et al., 2015).  60 
Arguably, the main disadvantage of using Artemia is their poor nutritional profile 61 
compared to that of copepods. This is particularly true with regards to essential lipids for marine 62 
fish larvae such as the eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 63 
22:6n-3) (Hamre et al., 2013; Izquierdo et al., 2000; Tocher, 2010). DHA is of particular 64 
importance during early stages of development and it is very abundant in the cell membranes 65 
of rapidly forming neural tissues (i.e. eye, brain) (Tocher and Harvie, 1988). EPA is a precursor 66 
of 3-series antagonistic prostaglandins that provide a low-inflammatory response (Tocher, 67 
2003). The analysis of marine finfish eggs is considered a good proxy of the lipid requirements 68 
of the fish. For instance, Atlantic cod and Atlantic halibut eggs contain around 14 % and 28 % 69 
of EPA and DHA, respectively (Bell et al., 2003) and copepods contained similar levels of 19 70 
% and 29 %, respectively (Hamre, 2016). On the contrary, Artemia contain low levels of EPA 71 
(< 5 %) and are devoid of DHA (Dhont et al., 2013; Navarro et al., 1999). It has clearly been 72 
demonstrated that the DHA/EPA ratio in the Artemia should be higher than 2 to fulfil the 73 
marine larvae’s requirements (Izquierdo et al., 2000; Sargent et al., 1999). Furthermore, the 74 
lipid fraction within copepods is characterised by high contents of polar lipids (PL) rich in n-3 75 
long-chain (≥C20) polyunsaturated fatty acids (LC-PUFA) including EPA and DHA, with 76 
levels of 24 and 41 % of the total fatty acids, respectively (Bell et al., 2003). On the other hand, 77 
Artemia are naturally rich in neutral lipids (NL) (e.g. triacylglycerol) and therefore have low 78 
levels of PLEPA (11.5-14.9 %) and PLDHA (0.6-2.4 %) (Bell et al., 2003). Some of these 79 
nutritional deficiencies, particularly in EFA, can be addressed to a certain extent through the 80 
so-called “bioencapsulation” or “enrichment”, which consists of exposing live preys to a 81 
culture medium containing essential nutrients that are passively filtered and incorporated into 82 
the digestive track of the live preys prior to their use as feed items (Monroig et al., 2003). 83 
Standard enrichment protocols have been successfully developed to enhance the LC-PUFA 84 
levels of live preys but boosting of PL contents in live preys has been proven to be more elusive 85 
(Guinot et al., 2013a; Monroig, 2003). Furthermore, it has been shown that LC-PUFA are more 86 
beneficial to the larvae when presented as PL (Cahu et al., 2003b; Gisbert et al., 2005; Kjørsvik 87 
et al., 2009; Rainuzzo et al., 1994). However, Artemia, rather than simply being passive carriers 88 
of enrichment products, can metabolise the PL contained in the enrichment diet into other lipid 89 
classes, particularly triacyglycerides (TAG), subsequently metabolising EFA from the PL 90 
fraction into the NL fraction (Guinot et al., 2013a; Guinot et al., 2013b; Monroig et al., 2006a, 91 
2003; Navarro et al., 1999). The supplementation of the standard enrichment diets with 92 
products rich in phospholipids (often referred to as “lecithins”) can therefore compensate for 93 
the inefficient bioencapsulation of PL within live preys (Guinot et al., 2013a; Monroig et al., 94 
2006a). Lecithins are typically composed of phosphatidylcholine (PC) as the most abundant 95 
phospholipid class, and the fatty acid composition varies depending on their origin and whether 96 
it is marine (e.g. krill lecithin) or terrestrial (e.g. soya lecithin). Finally, to avoid the loss of the 97 
Artemia nutritional value post-enrichment, hatcheries cold store the enriched nauplii at 5 to 10 98 
ºC. However, there is a lack of evidence on the fate of the essential lipids (i.e. EFA, PL) 99 
contained in the enriched nauplii following a short-term cold storage. 100 
This study aimed to develop enrichment protocols that enable the marine fish hatcheries 101 
to produce high quality Artemia nauplii that have enhanced levels of PL, while still 102 
guaranteeing the provision of EFA. First, an experiment was carried out to benchmark four 103 
commercially available enrichment products commonly used for Artemia enrichment in marine 104 
fish hatcheries (Exp. 1). Based on their enrichment efficiencies, the best performing enrichment 105 
product in terms of DHA content was subsequently used in a second experiment aiming at 106 
enhancing the PL content of enriched Artemia via a method referred to as “boosting” (Barr et 107 
al., 2005) involving a short-term incubation with phospholipid sources conducted after the 108 
standard enrichment process (Exp. 2). Finally, the effects of short-term cold storage on Artemia 109 
LC-PUFA content were also investigated in order to determine if a common practice in marine 110 
finfish hatcheries can impact on the nutritional profile of enriched Artemia.  111 
  112 
Materials and Methods  113 
Artemia hatching and culture 114 
Artemia cysts GSL (EG, Inve, Belgium) were decapsulated and hatched according to  115 
Sorgeloos et al. (2001). Enrichments were performed in 1-litre Imhoff cones with vigorous 116 
aeration from the bottom and constant light (light intensity at water surface: 47,000 lux, 1.78 117 
W m-2). The cones were filled with 32 ppt artificial seawater (Instant Ocean, USA) previously 118 
disinfected with Pyceze (0.05 ml l-1) and placed in a 28 °C water bath. After the 24 h hatching 119 
process, the nauplii were collected on a 100 µm sieve, rinsed with freshwater, and distributed 120 
in each cone at 300 nauplii ml-1 for further enrichment. 121 
Experiment 1: Benchmarking of Artemia enrichment products 122 
The four commercial enrichment products, commonly used in marine finfish hatcheries, 123 
were Larviva Multigain (MG, BioMar, Denmark), Ori-Go (OG, Skretting, Norway), Red 124 
Pepper (RP, Bernaqua, France) and Easy DHA Selco (SEL, Inve, Belgium). Enrichment diets 125 
stocks were prepared by emulsifying the required quantity of enrichment products in 1 litre of 126 
artificial seawater for 3 min using a domestic blender. The required volume of enrichment was 127 
then distributed to each 1-litre Imhoff cone filled with 800 ml of artificial seawater, resulting 128 
in concentrations of 0.6 g l-1 (MG, SEL and OG) and 1.5 g l-1 (RP), which was chosen based 129 
on ranging studies to keep the enrichment level within context of commercial guidelines but 130 
also to ensure comparable total lipid loading within enriched Artemia (Tables 1 and 3). Newly 131 
hatched Artemia nauplii were stocked in each cone at a density of 300 nauplii ml-1. Samples of 132 
enriched nauplii (24 h) were collected by concentrating them on a 100 µm sieve, thoroughly 133 
rinsed with freshwater to remove the excess of enrichment and gently dried on absorbent tissue 134 
and transferred to 15 ml plastic tubes. All samples were immediately frozen at -20 °C upon 135 
collection and subsequently freeze-dried and stored at -20 ºC for further analysis. 136 
Experiment 2: Boosting Artemia nauplii with phospholipids 137 
The enrichment product that showed the highest level of DHA and DHA/EPA ratio in 138 
Artemia nauplii in Exp. 1 (i.e. Larviva Multigain) was selected for Exp. 2, which aimed at 139 
increasing the PL contents of Artemia nauplii. Newly hatched Artemia nauplii were initially 140 
enriched with MG (0.6 g l-1) for 22 h in nine 1-litre Imhoff cones at a nauplii density of 300 141 
nauplii ml-1 (Table 1). Three cones were left under the same conditions for 2 h, thus resulting 142 
in 24 h enrichment with MG. Nauplii from six other cones (two triplicate treatments) were 143 
individually collected on a 100 µm sieve, rinsed with freshwater and placed back in the same 144 
Imhoff cones containing 800 ml of fresh artificial seawater. Nauplii from three of those cones 145 
were then subjected to a short-term (2 h) enrichment (“boosting”) with soya lecithin (Optima, 146 
UK) (Treatment MG+SL). The three others were boosted with marine lecithin (supplied by 147 
BioMar, UK) (Treatment MG+ML). Both soya and marine lecithins were supplied at 0.6 g l-1 148 
in the Imhoff cones, after emulsification of the boosting material in 1 litre of artificial seawater 149 
for 3 min. At 24 h, Artemia samples (approximately half of the population in each cone) from 150 
MG and boosting (MG+SL and MG+ML) treatments were collected for analysis as explained 151 
above. The other half of the enriched nauplii population was maintained at 5 ºC for 10 h in 152 
gently aerated seawater (“chilling”) prior to sample collection. This procedure aimed to 153 
simulate the standard production practice in marine finfish hatcheries whereby enriched 154 
Artemia are chilled below 10 °C to preserve their nutritional quality prior to being offered later 155 
in the daily feeding schedule. Overall, final sample set from Experiment 2 included enriched 156 
nauplii before boosting (22 h), enriched nauplii after boosting (24 h) and chilled nauplii (34 h). 157 
All samples were immediately frozen at -20 °C upon collection and subsequently freeze-dried 158 
and stored at -20 ºC until further analysis. 159 
Nutritional analysis  160 
Total lipids (TL) from enrichment products and lecithins, as well as freeze-dried Artemia 161 
samples collected from Exp. 1 and 2 were extracted according to Folch et al. (1957), with 162 
modifications as described by Monroig et al. (2006a). In order to analyse the fatty acid profiles 163 
of total polar lipids (PL) and total neutral lipids (NL) in Larviva Multigain, lecithins and 164 
Artemia nauplii in Exp. 2, these fractions were separated by loading 300 µl of TL solutions 165 
(circa 3 mg) onto a 20 x 20 cm silica gel thin-layer chromatography plate (Merck, Germany). 166 
The plate was run with a solvent mixture made of isohexane:diethylether:acetic acid (80/20/1, 167 
v/v/v) and subsequently sprayed with 2,7-dichlorofluorescein (0.1 %) dissolved in aqueous 168 
methanol (97 %, v/v). PL and NL were visualised under UV light, scrapped off the plate and 169 
transferred to separate test tubes. Fatty acid methyl esters (FAME) from TL, PL and NL were 170 
prepared, extracted and purified according to (Christie, 2003). Identification and quantification 171 
was carried out using a gas chromatograph (Thermo Trace GC Ultra, Thermo Electron 172 
Corporation, USA) as described by Houston et al. (2017).  173 
To calculate the percentage of PL and NL of the samples, lipid class analysis was 174 
conducted according to Henderson and Tocher (1992). Lipid classes were separated by double-175 
development, high-performance thin-layer chromatography (HPTLC). Total lipid samples (1-176 
2 μg) were applied and the plates developed in methyl 177 
acetate/isopropanol/chloroform/methanol/0.25 % aqueous KCl (25:25:25:10:9, v/v). Excess 178 
solvent was evaporated via air drying and vacuum desiccation and plates developed using a 179 
solvent mixture containing isohexane/diethyl ether/acetic acid (85:15:1.5, v/v). Lipid classes 180 
were visualised by spraying with 3 % (w/v) aqueous cupric acetate containing 8 % (v/v) 181 
phosphoric acid and charring plates at 160 °C for 25 min. Lipid classes were quantified by 182 
densitometry using a CAMAG-3 TLC scanner (version Firmware 1.14.16; CAMAG, Muttenz, 183 
Switzerland). 184 
To estimate total phospholipid content (Guinot et al., 2013b), total phosphorus was 185 
determined after digestion of freeze-dried Artemia samples in nitric acid (69 %) in a microwave 186 
(MARSXpress, CEM) for 40 min (20 min ramping to 120 ºC and 20 min holding that 187 
temperature). Digests were transferred into a volumetric flask and made up into x 25 dilutions 188 
with distilled water. Samples were analysed by Inductively Coupled Plasma Mass 189 
Spectrometry (ICP-MS, Thermo Scientific Model X Series 2, USA) as described by Smedley 190 
et al. (2016).  191 
Statistical analysis 192 
Enrichment diets used in Exp. 1 were analysed in technical duplicates and are expressed 193 
as means ± standard deviations (SD) (n = 2). All other data are expressed as means ± SD (n = 194 
3). Percentage data were transformed using the arcsine square root function. Normality and 195 
homogeneity of variance in the data were confirmed using Shapiro-Wilk and Levene’s tests, 196 
respectively. Data were analysed by one or two-way ANOVA followed by a Tukey’s post-hoc 197 
test at a significance level of P < 0.05. Individual fatty acid absolute values (i.e. mg FA g-1) are 198 
not presented in this paper but where nevertheless analysed similarly to that of relative values 199 
(i.e. % FA). Statistical differences for both values were the same unless specified otherwise. 200 
Phosphorus levels at 22 h and 24 h for each treatment were compared with a paired t-test (T < 201 
0.05). All data were analysed using SPSS (IBM SPSS Statistics 23, NY, USA). 202 
Results 203 
Experiment 1: benchmarking of Artemia enrichment products 204 
The total lipid content of the enrichment products greatly varied, ranging from 147.6 ± 205 
12.0 (RP) to 589.9 ± 2.0 mg g-1 (OG) (Table 2). The total fatty acid contents also greatly varied, 206 
ranging from 139.1 ± 21.7 (RP) to 376.2 ± 16.8 mg g-1 (SEL). In terms of EFA, the levels of 207 
ARA were similar across products, ranging from 1.2 ± 0.0 (MG) to 1.9 ± 0.0 % (RP). The 208 
levels of both EPA and DHA considerably varied, ranging from 0.8 ± 0.0 % (MG) to 7.5 ± 0.1 209 
% (SEL) and from 21.3 ± 0.1 % (SEL) to 36.6 ± 0.3 % (MG), respectively (Table 2).  210 
The total lipid content of the 24 h enriched nauplii did not vary significantly between the 211 
commercial enrichment products tested, ranging between 264.3 ± 19.4 (RP) and 287.5 ± 15.0 212 
mg g-1 (SEL) (Table 3). The polar lipid fraction was significantly lower in the nauplii enriched 213 
with OG (19.7 ± 2.3 %) while it was comparable between the other enrichments ranging 214 
between 31.0 ± 1.3 % (MG) and 34.7 ± 2.6 % (SEL). In terms of EFA, there were significant 215 
differences in the levels of ARA, EPA and DHA in relation to the enrichment products (Table 216 
3). Nauplii enriched with MG showed the highest levels of DHA (21.8 ± 0.7 %), which were 217 
25, 59 and 102 % higher than in the nauplii RP, OG and SEL, respectively. Interestingly, these 218 
DHA levels in the nauplii reflected the ones found in the corresponding enrichment products 219 
(Table 2). Furthermore, DHA/EPA ratios were all above 2, except for SEL (1.3 ± 0.0), and 220 
nauplii enriched with MG exhibited a significantly higher DHA/EPA ratio (3.8 ± 0.1).  221 
Regarding the other EFA, ARA levels were lowest for nauplii enriched with OG and SEL (1.5 222 
± 0.1 and 1.5 ± 0.0 %, respectively), then MG (2.9 ± 0.0 %) and lastly RP (3.1 ± 0.0 %). EPA 223 
levels were highest in SEL (8.1 ± 0.3 %) and lowest in MG (5.8 ± 0.2 %).   224 
Experiment 2: Boosting Artemia nauplii with phospholipids 225 
Prior to their use to boost phospholipid contents in Artemia, we analysed the two sources 226 
of phospholipids used in the present study, namely soya lecithin (SL) and marine lecithin (ML) 227 
(Tables 2 and 4). The total lipid content of both soya and marine lecithins varied from 801.3 ± 228 
10.1 (ML) to 864.1 ± 4.9 mg g-1 (SL) (Table 2). The PL fraction of the soya lecithin accounted 229 
for more than 86.2 ± 3.1 % of the total and in the case of the marine lecithin for 37.7 ± 1.1 % 230 
(Table 4). In terms of EFA, soya lecithin is devoid of ARA, EPA and DHA whereas the levels 231 
found in ML were 0.8 ± 0.0, 10.0 ± 0.4 and 19.1 ± 1.0 %, respectively, of total fatty acids 232 
(Table 2). When determining the location of EFA within NL or PL fractions of ML, ARA was 233 
found in both fractions (1.1 ± 0.2 and 0.6 ± 0.0 % for PL and NL, respectively). EPA levels 234 
were also found in both fractions of ML at levels of 9.8 %, while DHA was exclusively located 235 
in the PL fraction of ML (30.9 ± 0.3 %). On the contrary, DHA was mostly present in the NL 236 
fraction of MG (7.6 ± 0.2 and 43.8 ± 0.2 % for PL and NL, respectively) (Table 4). 237 
Total phosphorus (P), showed a significant increase in all three treatment groups between 238 
prior (22 h) and post (24 h) the boosting (Fig. 1). The change in P content pre- and post-239 
boosting, calculated as a percentage increase, was higher in the two treatments with lecithin 240 
sources such as soya lecithin (MG+SL, 16.7 % increase) and marine lecithin (MG+ML, 11.2 241 
%). When 24 h nauplii from all three treatments were compared, P content was significantly 242 
higher in the Artemia nauplii enriched with soya lecithin (MG+SL) in comparison to the nauplii 243 
enriched with just MG (Fig. 1).  244 
Total lipid contents of Artemia nauplii enriched for 24 h in Exp. 2 were not affected by 245 
either the chilling or the enrichment while total fatty acids were noted to significantly reduce 246 
in the MG+ML treatment in response to the 10hr chilling (Table 5). EPA, ARA and DHA levels 247 
were not significantly different in relation to enrichment protocols or in response to the chilling 248 
process. Equally, DHA/EPA ratios were not affected by either the chilling or the enrichment, 249 
ranging between 1.9 and 2.4. 250 
The inclusion of marine lecithin significantly decreased the PLARA in the nauplii (2.5 ± 251 
0.3 %) compared to that of the nauplii enriched with only MG (3.2 ± 0.2 %) (Table 6). However, 252 
the same marine lecithin significantly increased the PLEPA of the nauplii (8.0 ± 0.2 %) 253 
compared to that of the nauplii MG (6.7 ± 0.5 %) or MG+SL (5.9 ± 0.1 %) as well as the PLDHA 254 
in the nauplii enriched with MG+ML (10.6 ± 1.3 %) compared to MG (3.4 ± 0.7 %) or MG+SL 255 
(3.3 ± 0.4 %) (Table 6). Furthermore, the proportion of DHA in the PL and NL fractions (i.e. 256 
PLDHA/NLDHA ratio) was more than 5 times higher in the nauplii MG+ML (1.63) compared to 257 
that of the nauplii MG (0.24) and MG+SL (0.30). As for chilling, the levels of PLARA, PLEPA 258 
and PLn-3 were significantly increased after the chilling phase in all treatments while PLDHA 259 
remained unchanged. With regards to the NL fraction, the enrichments did not significantly 260 
affect the levels of the EFA within the neutral lipids. However, NLEPA and NLDHA of nauplii 261 
enriched with MG+ML increased significantly (>two-fold) following chilling (Table 6).  262 
Discussion 263 
Marine finfish larvae production is constrained by low survival, developmental 264 
impairment and deformities that are often attributed to deficiencies in essential lipids such as 265 
phospholipids and LC-PUFA in larval diets (Cahu et al., 2003a; Hamre et al., 2013; Izquierdo 266 
et al., 2000). Based on the lipid composition of wild copepods, dietary provision of EFA, 267 
particularly DHA in the form of PL, would be critical to normal development and survival of 268 
marine fish larvae (Gisbert et al., 2005; Tocher et al., 2008). The benefits of feeding marine 269 
fish larvae with copepods compared to other live preys (i.e. rotifers, Artemia) have been 270 
extensively reported (Karlsen et al., 2015; Øie et al., 2015; Støttrup, 2000). However 271 
availability of wild copepods for marine fish hatcheries is very limited and seasonal (Støttrup, 272 
2000). Consequently, it is crucial to develop sound enrichment strategies for live preys such as 273 
Artemia resulting in EFA-rich PL, thus mimicking the copepod’s lipid profile. The copepod’s 274 
lipid composition is mainly characterised by high contents of PL including high levels of DHA 275 
(van der Meeren et al., 2008). Increasing PLDHA can be achieved in microdiets by including 276 
marine ingredients (Gisbert et al., 2005) but it has been proven difficult in live preys such as 277 
Artemia due to the limited efficiency of the enrichment process, along with the occurrence of 278 
undesired metabolic conversions that live preys exert on enrichment products (Ando et al., 279 
2004; Ando and Narukawa, 2002; Ando and Oomi, 2001; Navarro et al., 1999; Shiozaki and 280 
Ando, 2005). The present study showed that boosting a commercial Artemia enrichment using 281 
soya lecithin can increase the nauplii’s phospholipids level while boosting with marine lecithin 282 
results in nauplii presenting similar EFA and/or PL profiles to that of copepods. 283 
The importance of EFA including ARA, EPA and DHA on growth and development of 284 
marine fish larvae has been previously reported (Bell et al., 1986; Rainuzzo et al., 1997; Tocher, 285 
2010). DHA is very important during the early developmental stages since cell membranes of 286 
rapidly forming neural tissues (i.e. eye, brain) are particularly rich in DHA (Tocher and Harvie, 287 
1988). This is especially true for marine fish larvae, compared to freshwater species, which 288 
generally have a low capacity for de novo synthesis of DHA (Castro et al., 2016) and therefore 289 
are almost exclusively dependent upon dietary DHA input from live preys. The first experiment 290 
of the present research consisted in a benchmark study of commercially available enrichment 291 
products for Artemia which are commonly used in marine finfish hatcheries. Our results 292 
showed that following correction to comparable levels of total lipid enrichment, Artemia 293 
enriched with MG exhibited the highest DHA content (i.e. 21.8 ± 0.7 %), reaching comparable 294 
levels as those found by Boglino et al. (2012) (i.e. 16.9 ± 2.0 %) where a similar Artemia 295 
enrichment protocol using MG was used. Interestingly, the observed DHA contents in Artemia 296 
nauplii were twice as high as those reported in the literature when using DHA-rich enrichment 297 
products (Viciano et al., 2015). This reflects the high DHA content of MG compared to other 298 
enrichments used in this study or in the literature. These results confirmed that DHA content 299 
is highly variable between enrichment products (Monroig et al., 2006b; Sorgeloos et al., 2001). 300 
Interestingly, the levels of DHA in the nauplii did not reflect those of the enrichment products 301 
themselves and where lower in all enriched nauplii compared to the respective enrichment 302 
product. An increase in EPA was also found in Artemia nauplii enriched with MG (5.8 ± 0.2 303 
%), despite a low EPA content in MG (0.8 ± 0.0 %). This was very likely due to the 304 
“retroconversion”, a metabolic process demonstrated in Artemia by which DHA is converted 305 
into EPA (Guinot et al., 2013a; Han et al., 2001; Navarro et al., 1999; Viciano et al., 2017). 306 
However, the MG enrichment product still delivered the highest DHA/EPA ratio (i.e. 3.8 ± 0.1 307 
%) of all treatments. It should be noted that while results are presented in terms of % total lipid, 308 
the total lipid and fatty acid contents in the enriched nauplii were comparable across treatments 309 
thus if the results are considered in an absolute basis (i.e. mg FA g-1) the same conclusion is 310 
found (data not shown). Finally, the PL content in the nauplii MG was among the highest ones 311 
(31.0 ± 1.3 %), including the nauplii RP and SEL. Based on these results, MG was selected as 312 
the enrichment product for Exp. 2. 313 
Exp. 2 aimed to boost Artemia nauplii in PL after standard MG enrichment and compare 314 
the efficiency of marine (37.7 ± 1.1 % PL and 30.9 ± 0.3 % PLDHA) vs. soya (86.2 ± 3.1 % PL 315 
and no PLDHA) lecithins. As opposed to the studies by Guinot et al. (2013a, 2013b) and Monroig 316 
et al. (2003, 2006a, 2006b), which adopted the use of liposomes to deliver phospholipids, this 317 
current study trialled a technically simpler alternative method to boost phospholipids and 318 
essential fatty acids in Artemia nauplii. Our results showed that soya lecithin was able to 319 
significantly enhance the PL content of Artemia compared to MG. Nevertheless, the PL levels 320 
in the MG+ML enriched Artemia appeared to be higher than nauplii MG, although not 321 
significantly. This is in agreement with findings from previously published studies using 322 
slightly different enrichment protocols (Guinot et al., 2013a; Guinot et al., 2013b; Rainuzzo et 323 
al., 1994). The present results confirm that the “boosting” first described by Barr et al. (2005) 324 
is not only an effective way to increase PL contents in live preys enriched using oil emulsion-325 
based products (e.g. Guinot et al., 2013a,b), but also with spray-dried algae cell products such 326 
as Larviva Multigain used in the present study. Clearly, soya lecithin was, as discussed above, 327 
an efficient product to enhance the total PL content of MG+SL nauplii but the PLDHA was not 328 
increased compared to the MG. On the contrary, the marine lecithin, while not being such an 329 
efficient product to enhance total PL in Artemia as SL, did significantly increase the PLDHA, 330 
reaching levels three-fold over those of MG. This work clearly demonstrates that marine 331 
lecthins are required to effectively boost DHA within polar lipids, which are regarded as the 332 
more bioavailable molecular form to present this EFA to marine larvae and as found in the wild 333 
copepods (Bell et al., 2003; Gisbert et al., 2005; Tocher, 2010). Nevertheless, soya lecithin 334 
contains good phospholipids (mainly PC) irrespective of EFA, and is 10 to 30 times cheaper 335 
than marine lecithin, which may still be of benefit to the hatcheries. Ultimately, the hereby 336 
presented enrichment boosting strategies should be implemented in a fish trial to qualify the 337 
benefits of the EFA-rich PL Artemia on the survival and growth of the larvae. 338 
The development of marine fish larviculture depends upon the quality and consistency 339 
of the nutritional value of live feeds, which themselves are dependent upon the enrichment 340 
protocols. As marine fish larvae are fed throughout the day this requires that hatcheries employ 341 
strategies to preserve the nutritional quality of the Artemia up to 10 h post enrichment while 342 
also assuring that the quality of the enriched live preys is constant from one day to another. In 343 
order to achieve this, hatchery procedures often involve cold storage of the enriched live preys 344 
to preserve their nutritional value. Results from the present study showed that the cold storage 345 
(5 ºC) of enriched Artemia for up to 10 h did not have a major effect on the total lipid and EFA 346 
composition of the nauplii. However, variations were observed within the polar and neutral 347 
lipid fractions. For instance, PLEPA in all treatments increased in the region of 19-29 % after 348 
chilling. Although this could have been attributed to the retroconversion of DHA into EPA 349 
taking place in the nauplii (Navarro et al., 1999), the levels of PLDHA remained constant after 350 
chilling. Another variation was that NLEPA and NLDHA in the nauplii MG+ML increased by 351 
more than two fold after chilling with a similar, though not significant, pattern being observed 352 
in the nauplii MG and MG+SL. Since it has been shown that good marine larvae growth and 353 
survival greatly relies on Artemia nauplii containing high levels of PLDHA (Gisbert at al., 2005), 354 
attention should be put into methods to compensate or inhibit the relocation of PLDHA into NL 355 
(e.g. TAG) in order to preserve the quality of the enriched Artemia.  While the drivers of the 356 
observed change are not fully understood at present, it can be concluded that chilling is an 357 
efficient way to preserve the nutritional quality of the nauplii at a total lipid level. However, 358 
the differences observed at the polar/neutral lipid levels require further investigation in order 359 
to conclude at this level.  With regards to the nutritional quality of the live preys from one day 360 
to another, an important aspect of the study was that in the Artemia nauplii from Exp. 2, the 361 
levels of DHA were remarkably lower (circa 50% reduction) compared to the nauplii enriched 362 
with MG in Exp. 1, while the same enrichment product and protocol was used, in both 363 
experiments. This shows the high variability in Artemia enrichment even in a small-scale, 364 
highly controlled experimental system. While the enrichment protocol is standardised, other 365 
factors such as aeration, water flows in the culture and enrichment cones are  more challenging 366 
to standardise and could be associated with such variation (Monroig et al., 2006a; Navarro et 367 
al., 1999). Artemia nauplii intake the enrichment product by filtration, therefore slight changes 368 
in the enrichment parameters may affect the naupliar filtering capacity, ultimately affecting the 369 
composition of the enriched Artemia nauplii. This variability in the enrichment of live feed can 370 
be even greater in large-scale systems and this constitutes a major challenge for commercial 371 
hatcheries. In order to guarantee the supply of high quality enriched Artemia, all aspects of the 372 
enrichment protocol must be standardised at all times to maintain optimal live prey nutritional 373 
quality in tune with the species nutritional requirements.  374 
In conclusion, when comparing four commercial enrichment products Larviva Multigain 375 
produced enriched Artemia with the highest  levels of DHA, an EFA particularly important for 376 
larval stages of marine finfish. When this enrichment is further boosted with either marine or 377 
soya lecithin products, the polar lipid fraction is notably increased in the enriched Artemia. 378 
However, while marine lecithin is a good candidate to boost Artemia nauplii enrichment in 379 
both PL and EFA with notable elevation of PLDHA, soya lecithin did not increase the EFA 380 
content of the PL fraction in comparison to standard enrichment. Overall, this study has 381 
demonstrated a technically simple means to significantly enhance phospholipid and/or EFA 382 
content of enriched Artemia that could benefit marine finfish larviculture. 383 
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Table 1. Summary of the different treatments tested in Exp. 1 (benchmarking of commercial Artemia enrichment 









Larviva Multigain (MG) 0.6 g l-1 
24 h 300 Ori-Go (OG) 0.6 g l-1 
Red Pepper (RP) 1.5 g l-1 
Easy DHA Selco (SEL) 0.6 g l-1   
Experiment 2 
 
Larviva Multigain 0.6 g l-1 24 h 
300 
Larviva Multigain 
+ soya lecithin (MG+SL) 
MG 0.6 g l-1 




+ marine lecithin (MG+ML) 
MG 0.6 g l-1 
ML 0.6 g l-1 
22 h 
2 h 
     
 
  
Table 2. Total lipids and selected fatty acids in the enrichment products (Larviva Multigain, Ori-Go, Red Pepper 
and Easy DHA Selco) and the lecithins (soya or marine lecithin) used in the enrichment diet preparation for Exp. 
1 and 2.  
 Enrichment product Lecithins 
 MG OG RP SEL SL ML 
Total lipids (mg g-1 DW) 397.4 ± 12.8 589.9 ± 2.0 147.6 ± 12.0 352.4 ± 18.7 864.1 ± 4.9 801.5 ± 10.1 
Total FA (mg g-1 DW) 276.9 ± 6.7 178.2 ± 0.7 139.1 ± 21.7 376.2 ± 16.8 405.9 ± 3.6 459.1 ± 32.7 
% of total FA       
14:0 6.1 ± 0.1 1.8 ± 0.1 8.5 ± 0.1 2.9 ± 0.0 0.1 ± 0.0 4.4 ± 0.2 
15:0 0.4 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 0.7 ± 0.0 ND 0.6 ± 0.0 
16:0 32.3 ± 0.4 19.6 ± 0.2 36.7 ± 0.6 17.7 ± 0.0 19.3 ± 0.1 21.8 ± 0.6 
18:0 0.9 ± 0.0 5.2 ± 0.2 1.2 ± 0.0 4.8 ± 0.0 3.9 ± 0.0 4.0 ± 0.1 
Saturates 40.1 ± 0.5 27.9 ± 0.1 47.3 ± 0.8 26.7 ± 0.0 24.3 ± 0.1 31.3 ± 0.9 
16:1n-9 0.3 ± 0.0 2.9 ± 0.3 ND 4.6 ± 0.1 ND 5.5 ± 0.2 
16:1n-7 0.1 ± 0.0 0.1 ± 0.0 1.3 ± 0.0 0.2 ± 0.0 ND 0.3 ± 0.0 
18:1n-9 1.9 ± 0.0 15.9 ± 0.2 2.2 ± 0.0 19.2 ± 0.1 8.5 ± 0.1 16.0 ± 0.4 
18:1n-7 ND 2.1 ± 0.4 0.5 ± 0.0 2.9 ± 0.1 1.4 ± 0.0 2.8 ± 0.1 
Monounsaturates 2.3 ± 0.0 23.1 ± 1.1 4.1 ± 0.1 28.7 ± 0.3 10.2 ± 0.1 30.5 ± 0.8 
18:2n-6 2.2 ± 0.0 13.5 ± 0.4 4.5 ± 0.1 5.7 ± 0.1 58.1 ± 0.1 1.2 ± 0.0 
18:3n-6 0.2 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 ND 0.1 ± 0.0 
20:4n-6 (ARA) 1.2 ± 0.0 1.4 ± 0.1 1.9 ± 0.0 1.6 ± 0.1 ND 0.8 ± 0.0 
22:5n-6 14.4 ± 0.2 1.5 ± 0.1 10.0 ± 0.2 1.2 ± 0.1 ND 0.2 ± 0.0 
Total n-6  18.4 ± 0.2 17.3 ± 0.6 16.9 ± 0.3 9.4 ± 0.3 58.2 ± 0.1 2.9 ± 0.1 
18:3n-3 0.3 ± 0.0 2.5 ± 0.1 0.3 ± 0.0 1.6 ± 0.0 7.1 ± 0.0 1.1 ± 0.0 
18:4n-3 0.3 ± 0.0 0.5 ± 0.3 0.4 ± 0.0 1.0 ± 0.0 ND 2.2 ± 0.0 
20:3n-3 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 ND 0.1 ± 0.0 
20:4n-3 0.7 ± 0.1 0.3 ± 0.0 0.6 ± 0.0 0.5 ± 0.0 ND 0.7 ± 0.0 
20:5n-3 (EPA) 0.8 ± 0.0 4.6 ± 0.9 2.2 ± 0.0 7.5 ± 0.1 ND 10.0 ± 0.4 
22:5n-3 0.3 ± 0.0 1.2 ± 0.1 0.4 ± 0.0 1.8 ± 0.0 ND 1.2 ± 0.1 
22:6n-3 (DHA) 36.6 ± 0.3 21.6 ± 1.0 28.1 ± 0.1 21.3 ± 0.1 ND 19.1 ± 1.0 
Total n-3  39.0 ± 0.4 30.8 ± 0.6 32.1 ± 0.1 33.8 ± 0.0 7.3 ± 0.0 34.4 ± 1.6 
DW: dry weight; FA: fatty acids; MG: Larviva Multigain; ML: marine lecithin; ND: not detected; OG: Ori-Go; RP: Red 






Table 3. Total lipids, polar lipids, neutral lipids and fatty acid profiles in the Artemia nauplii from Exp. 1 enriched 
24 h with four commercial enrichment products. Data are expressed as means ± standard deviations (n = 3). 
Superscripts denote significant differences between treatments (one-way ANOVA and Tukey’s test, P < 0.05). 
 MG OG RP SEL 
Total lipids (mg g-1 DW) 285.1 ± 1.5 278.7 ± 11.1 264.3 ± 19.4 287.5 ± 15.0 
Polar lipids (% of TL) 31.0 ± 1.3b 19.7 ± 2.3a 33.8 ± 1.2b 34.7 ± 2.6b 
Neutral lipids (% of TL) 69.0 ± 1.3a 80.3 ± 2.3b 66.2 ± 1.2a 65.3 ± 2.6a 
Total FA (mg g-1 DW) 188.3 ± 13.7 187.9 ± 33.5 184.5 ± 2.4 193.2 ± 17.7 
% of total FA     
14:0 1.7 ± 0.1c 0.7 ± 0.0a 2.5 ± 0.1d 1.1 ± 0.0b 
15:0 0.2 ± 0.0a 0.2 ± 0.0b 0.2 ± 0.0b 0.3 ± 0.0c 
16:0 14.1 ± 0.7b 10.4 ± 0.3a 15.7 ± 0.2c 11.3 ± 0.4a 
18:0 3.8 ± 0.1a 4.4 ± 0.2bc 4.0 ± 0.1ab 4.6 ± 0.2c 
Saturates 20.0 ± 1.1b 16 ± 0.6a 22.7 ± 0.2c 17.7 ± 0.7a 
16:1n-9 0.9 ± 0.0 1.2 ± 1.0 0.4 ± 0.0 2.5 ± 1.6 
16:1n-7 ND 1.5 ± 1.3 1.5 ± 0.0 1.1 ± 1.9 
18:1n-9 10.9 ± 0.5a 18.4 ± 0.7b 10.4 ± 0.1a 21.9 ± 0.6c 
18:1n-7 3.1 ± 0.1a 4.3 ± 0.3b 3.3 ± 0.0a 5.3 ± 0.1c 
Monounsaturates 15.3 ± 0.3a 26.5 ± 0.6b 16.1 ± 0.1a 32.1 ± 0.3c 
18:2n-6 4.9 ± 0.1a 12.0 ± 0.2c 6.6 ± 0.2b 6.5 ± 0.1b 
18:3n-6 0.5 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 
20:4n-6 (ARA) 2.9 ± 0.0b 1.5 ± 0.1a 3.1 ± 0.0c 1.5 ± 0.0a 
22:5n-6 8.1 ± 0.3d 1.0 ± 0.2b 5.8 ± 0.0c 0.6 ± 0.0a 
Total n-6  16.7 ± 0.2c 15.5 ± 0.2b 16.4 ± 0.2c 9.4 ± 0.1a 
18:3n-3 15.5 ± 0.7 16.2 ± 0.9 15.5 ± 0.0 15.7 ± 0.5 
18:4n-3 2.4 ± 0.1 2.4 ± 0.1 2.5 ± 0.1 2.4 ± 0.1 
20:3n-3 0.7 ± 0.0 0.7 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 
20:4n-3 1.0 ± 0.0d 0.7 ± 0.0a 0.9 ± 0.0c 0.8 ± 0.0b 
20:5n-3 (EPA) 5.8 ± 0.2a 6.5 ± 0.5ab 6.6 ± 0.1b 8.1 ± 0.3c 
22:5n-3 0.4 ± 0.0a 0.9 ± 0.1b 0.4 ± 0.0a 1.1 ± 0.0c 
22:6n-3 (DHA) 21.8 ± 0.7d 13.7 ± 1.6b 17.5 ± 0.1c 10.8 ± 0.7a 
Total n-3  47.6 ± 0.9c 41.2 ± 1.1a 44.1 ± 0.1b 39.7 ± 0.5a 
DHA/EPA 3.8 ± 0.1d 2.1 ± 0.1b 2.7 ± 0.0c 1.3 ± 0.0a 
DHA/EPA: docosahexaenoic and eicosapentaenoic fatty acid ratio; DW: dry weight; FA: 





Table 4. Selected fatty acids in the polar lipid (PL) and neutral lipid (NL) fractions of the Larviva Multigain 
(MG), soya lecithin and marine lecithin used in Exp. 2. 
Products MG Soya lecithin Marine lecithin 
Lipid fraction PL NL PL NL PL NL 
% of total lipids 28.6 ± 0.0  71.4 ± 0.0 86.2 ± 3.1  13.8 ± 3.1 37.7 ± 1.1   62.3 ± 1.1 
% of total FA       
14:0 0.5 ± 0.0 6.3 ± 0.0 0.1 ± 0.1 2.3 ± 0.0 1.4 ± 0.0 4.5 ± 0.1 
15:0 0.2 ± 0.0 0.3 ± 0.0 0.1 ± 0.0 ND 0.4 ± 0.0 0.6 ± 0.0 
16:0 56.2 ± 0.1 27.6 ± 0.2 21.1 ± 0.1 25.7 ± 0.1 19.9 ± 0.0 20.2 ± 0.0 
18:0 1.9 ± 0.0 0.7 ± 0.1 4.4 ± 0.1 9.6 ± 0.0 5.0 ± 0.1 3.5 ± 0.1 
Saturates 59.0 ± 0.1 35.1 ± 0.1 26.7 ± 0.0 37.6 ± 0.1 28.0 ± 0.0 42.8 ± 0.0 
16:1n-9 ND ND ND 5.3 ± 0.1 2.9 ± 0.0 0.3 ± 0.1 
16:1n-7 0.5 ± 0.0 0.2 ± 0.0 0.1 ± 0.1 ND 2.5 ± 0.1 5.8 ± 0.0 
18:1n-9 11.8 ± 0.0 0.4 ± 0.0 8.9 ± 0.1 15.2 ± 0.0 11.0 ± 0.0 16.6 ± 0.1 
18:1n-7 0.5 ± 0.1 0.1 ± 0.0 1.5 ± 0.1 2.0 ± 0.1 3.1 ± 0.1 2.5 ± 0.0 
Monounsaturates 12.9 ± 0.1 0.7 ± 0.1 10.7 ± 0.1 22.6 ± 0.1 30.9 ± 0.0 32.9 ± 0.1 
18:2n-6 14.4 ± 0.0 0.5 ± 0.1 55.9 ± 0.0 30.9 ± 0.0 1.0 ± 0.0 1.1 ± 0.1 
18:3n-6 ND 0.2 ± 0.0 ND ND ND 0.1 ± 0.0 
20:4n-6 (ARA) ND 1.3 ± 0.1 ND ND 1.1 ± 0.2 0.6 ± 0.0 
22:5n-6 1.6 ± 0.0 10.1 ± 0.1 ND ND ND 0.2 ± 0.1 
Total n-6  16.1 ± 0.1 12.6 ± 0.1 55.9 ± 0.2 33.0 ± 0.0 2.1 ± 0.0. 2.3 ± 0.0 
18:3n-3 1.2 ± 0.0 0.1 ± 0.1 6.6 ± 0.2 3.6 ± 0.0 0.5 ± 0.0 1.1 ± 0.0 
18:4n-3 0.3 ± 0.1 0.2 ± 0.1 ND 3.2 ± 0.2 0.5 ± 0.0 2.6 ± 0.0 
20:3n-3 ND 0.1 ± 0.0 ND ND ND ND 
20:4n-3 ND 0.8 ± 0.0 ND ND 0.4 ± 0.2 0.8 ± 0.1 
20:5n-3 (EPA) 0.4 ± 0.1 0.8 ± 0.1 ND ND 9.8 ± 0.4 9.8 ± 0.0 
22:5n-3 ND 0.3 ± 0.0 ND ND 1.0 ± 0.2 1.3 ± 0.2 
22:6n-3 (DHA) 7.6 ± 0.2 41.2 ± 0.1 ND ND 30.9 ± 0.3 ND 
Total n-3  9.7 ± 0.1 43.8 ± 0.2 6.6 ± 0.2 6.8 ± 0.3 43.4 ± 0.1 15.8 ± 0.1 







Table 5. Total lipids and selected fatty acids in the Artemia nauplii from Exp. 2 enriched with Larviva Multigain 
(24 h, MG), Larviva Multigain (22 h) boosted with soya lecithin (2 h) (MG+SL) and Larviva Multigain (22 h) 
boosted with marine lecithin (2 h) (MG+ML). Lipid and fatty acid profiles from Artemia nauplii maintained at 5 
C for 10 h (Chilled) post enrichment are also shown. Data are expressed as means ± standard deviations (n = 3). 
Data that do not share the same letter among enrichments in the same phase differ significantly and * denotes a 
significant difference within a same treatment between 24 h and Chilled (two-way ANOVA and Tukey’s test, P 
< 0.05). 
Phase 24 h Chilled 
Enrichment MG MG+SL MG+ML MG MG+SL MG+ML 
Total lipid (mg g-1 DW) 199.7 ± 19.7 277.2 ± 66.8 266.5 ± 26.5 193.0 ± 13.6 197.1 ± 17.1 244.4 ± 57.4 
Total fatty acids (mg g-1 DW) 128.7 ± 11.9 197.7 ± 71.3 173.0 ± 7.3* 121.3 ± 17.4 122.5 ± 13.4 135.9 ± 26.2* 
% of total FA       
14:0 1.5 ± 0.1 1.7 ± 0.6 2.0 ± 0.5 1.4 ± 0.0 1.3 ± 0.0 1.8 ± 0.5 
15:0 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.2 0.8 ± 0.1 0.9 ± 0.1 
16:0 15.2 ± 1.1 16 ± 1.1 15.5 ± 1.6 14.1 ± 1.2 14.1 ± 0.8 14.7 ± 1.8 
18:0 4.7 ± 0.6 4.8 ± 0.4 4.3 ± 0.3 4.8 ± 0.6 4.8 ± 0.4 4.5 ± 0.3 
Saturates 22.7 ± 1.7 23.9 ± 1.8 23.1 ± 2.4 21.5 ± 2.1 21.4 ± 1.3 22.4 ± 2.6 
16:1n-9 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.1 0.5 ± 0.0 0.6 ± 0.0 
16:1n-7 1.3 ± 0.2 1.7 ± 1.0 2.0 ± 0.9 1.3 ± 0.3 1.2 ± 0.1 2.1 ± 0.6 
18:1n-9 13.2 ± 1.5 14.1 ± 1.5 13.4 ± 1.6 13.7 ± 1.9 13.3 ± 0.6 14.8 ± 1.3 
18:1n-7 4.1 ± 0.5 4.0 ± 0.2 3.7 ± 0.2 4.2 ± 0.7 4.0 ± 0.2 4.1 ± 0.5 
Monounsaturates 20.1 ± 2.4 21.8 ± 3.8 21.4 ± 3.8 20.7 ± 3.0 20.0 ± 0.9 23.3 ± 2.6 
18:2n-6 4.9 ± 0.2 8.7 ± 4.2 5.8 ± 2.9 5.1 ± 0.3a 9.6 ± 2.1b 4.4 ± 0.7a 
18:3n-6 0.5 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.5 ± 0.0 0.4 ± 0.0 0.4 ± 0.1 
20:4n-6 (ARA) 2.5 ± 0.2 2.1 ± 0.3 2.2 ± 0.3 2.7 ± 0.3 2.5 ± 0.2 2.3 ± 0.3 
22:5n-6 5.0 ± 1.6 3.5 ± 1.0 4.6 ± 1.4 4.9 ± 1.7 4.3 ± 1.0 4.0 ± 1.4 
Total n-6  13.5 ± 1.7 15.2 ± 5.0 13.5 ± 4.3 13.8 ± 1.9ab 17.4 ± 0.9b 11.7 ± 2.3a 
18:3n-3 20.2 ± 2.0 18.1 ± 2.8 16.4 ± 1.8 20.5 ± 2.0 19.5 ± 1.0 17.1 ± 3.2 
18:4n-3 2.9 ± 0.2 2.6 ± 0.0 2.6 ± 0.1 2.9 ± 0.3b 2.6 ± 0.1a 2.7 ± 0.2ab 
20:3n-3 0.9 ± 0.0b 0.8 ± 0.1ab 0.7 ± 0.1a 0.9 ± 0.0 0.8 ± 0.0 0.8 ± 0.1 
20:4n-3 0.9 ± 0.1 0.8 ± 0.0 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 
20:5n-3 (EPA) 5.0 ± 0.4 5.1 ± 1.2 6.0 ± 0.8 5.5 ± 0.7 5.2 ± 0.6 6.7 ± 0.8 
22:5n-3 0.3 ± 0.1 0.4 ± 0.2 0.5 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.5 ± 0.1 
22:6n-3 (DHA) 12.1 ± 4.2 10.1 ± 2.1 13.9 ± 2.0 11.8 ± 4.6 10.5 ± 3.0 12.8 ± 2.8 
Total n-3  42.4 ± 2.5 37.9 ± 1.6 40.9 ± 2.7 42.8 ± 3.2 39.8 ± 2.7 41.4 ± 2.8 
DHA/EPA 2.4 ± 0.7 2.0 ± 0.3 2.4 ± 0.5 2.1 ± 0.6 2.0 ± 0.4 1.9 ± 0.5 
DHA/EPA: docosahexaenoic and eicosapentaenoic fatty acid ratio; DW: dry weight; FA: fatty acids; TL: total lipids. 
Table 6. Fatty acid levels of total polar lipids (PL) and total neutral lipids (NL) of Artemia nauplii from Exp. 2 enriched with Larviva Multigain (24 h, MG), Larviva Multigain (22 h) boosted 
with soya lecithin (2 h) (MG+SL) and Larviva Multigain (22 h) boosted with marine lecithin (2 h) (MG+ML). Data are expressed as means ± standard deviations (n = 3). Data that do not share 
the same letter among enrichments in the same phase (24 h or Chilled) differ significantly and * denotes a significant difference within a same treatment between 24 h and Chilled (two-way 
ANOVA and Tukey’s test, P < 0.05). 
Lipid fraction PL      NL      
Phase 24 h   Chilled   24 h   Chilled   
Enrichment MG MG+SL MG+ML MG MG+SL MG+ML MG MG+SL MG+ML MG MG+SL MG+ML 
% of total FA             
14:0 1.4 ± 0.3 1.3 ± 0.4 1.8 ± 0.2 1.1 ± 0.2 1.0 ± 0.1 1.3 ± 0.2 1.8 ± 0.0a 1.8 ± 0.1a 3.0 ± 0.5b 1.4 ± 0.0 1.3 ± 0.0 1.7 ± 0.5 
15:0 0.2 ± 0.0ab 0.2 ± 0.0a 0.3 ± 0.0b 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.1 0.3 ± 0.0a 0.3 ± 0.0a 0.4 ± 0.1b 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.1 
16:0 14.8 ± 0.4a 14.7 ± 0.5a 16.4 ± 0.6b 12.2 ± 0.1 12.2 ± 0.4 13.4 ± 1.9 16.7 ± 1.6 17.8 ± 1.7 20.4 ± 1.7 14.9 ± 1.4 14.6 ± 1.3 14.9 ± 1.8 
18:0 10.3 ± 0.2 12.2 ± 4.7 8.4 ± 0.2 9.2 ± 0.3 9.0 ± 0.3 8.2 ± 0.8 3.5 ± 0.4 4.0 ± 0.4 4.3 ± 0.3 3.5 ± 0.4 3.4 ± 0.3 3.3 ± 0.2 
Saturates 27.5 ± 0.4 29.2 ± 5.7 27.6 ± 0.5 23.5 ± 0.1 23.1 ± 0.6 23.9 ± 1.5 22.6 ± 2.1 24.3 ± 2.1 28.5 ± 2.4 20.3 ± 1.9 19.8 ± 1.7 20.5 ± 2.6 
16:1n-9 1.2 ± 0.1ab 0.7 ± 0.5a 2.1 ± 0.2b 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 1.5 ± 0.3 0.9 ± 0.4 0.7 ± 0.1 0.6 ± 0.1 0.6 ± 0.0 0.6 ± 0.0 
16:1n-7 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 1.1 ± 0.0a 1.0 ± 0.1a 1.8 ± 0.5b 0.1 ± 0.0a 0.2 ± 0.0a 3.4 ± 0.8b 1.5 ± 0.3 1.3 ± 0.1 2.4 ± 0.8 
18:1n-9 19.4 ± 0.7 14.3 ± 6.2 17.7 ± 0.2 18.7 ± 0.9 17.6 ± 0.7 18.1 ± 1.8 12.4 ± 1.7a 13.5 ± 1.3ab 16.7 ± 1.0b 12.5 ± 1.9 11.9 ± 0.7 13.9 ± 1.5 
18:1n-7 8.1 ± 0.3 9.0 ± 2.8 6.8 ± 0.2 7.7 ± 0.1 7.4 ± 0.2 7.2 ± 1.0 3.5 ± 0.6 3.6 ± 0.4 4.1 ± 0.1 3.6 ± 0.6 3.3 ± 0.3 3.6 ± 0.3 
Monounsaturates 29.7 ± 0.9b 24.9 ± 2.8a 27.8 ± 0.3ab 28.9 ± 1.1 27.3 ± 1.1 28.8 ± 2.1 18.1 ± 2.7a 18.7 ± 1.8a 27.1 ± 2.6b 18.7 ± 2.9 17.6 ± 1.2 22.0 ± 3.2 
18:2n-6 6.2 ± 0.0 8.7 ± 7.2 4.7 ± 0.4 6.0 ± 0.1 10.6 ± 0.6 5.2 ± 1.0 4.9 ± 0.3a 9.9 ± 2.6b 5.0 ± 1.1a 5.0 ± 0.4a 9.8 ± 2.3b 4.3 ± 0.5a 
18:3n-6 0.2 ± 0.2 0.2 ± 0.2 0.1 ± 0.0 0.5 ± 0.0 0.4 ± 0.0 0.4 ± 0.1 0.5 ± 0.0b 0.2 ± 0.2a 0.1 ± 0.0a 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 
20:4n-6 (ARA) 3.2 ± 0.2b 2.8 ± 0.1ab 2.5 ± 0.3a 3.7 ± 0.3 3.4 ± 0.2 2.9 ± 0.5 2.2 ± 0.3 2.0 ± 0.3 2.1 ± 0.5 2.6 ± 0.4 2.5 ± 0.3 2.3 ± 0.3 
22:5n-6 1.5 ± 0.4 1.4 ± 0.2 1.2 ± 0.3 1.7 ± 0.4 1.5 ± 0.4 1.4 ± 0.5 5.7 ± 1.8 4.6 ± 1.5 4.9 ± 2.1 6.0 ± 2.1 5.4 ± 1.3 5.0 ± 1.4 
Total n-6 11.6 ± 0.8 13.6 ± 7.1 9.0 ± 1.0 12.4 ± 0.8 16.5 ± 0.5 10.4 ± 2.0 13.9 ± 1.9 17.1 ± 1.3 12.7 ± 3.8 14.7 ± 2.2ab 18.7 ± 1.1b 12.6 ± 2.0a 
18:3n-3 15.9 ± 1.1b 15.4 ± 1.4b 12.2 ± 0.9a 17.0 ± 1.1 16.3 ± 0.4 14.1 ± 3.3 21.6 ± 2.4 20.3 ± 0.7 18.6 ± 2.1 21.4 ± 3.2 20.7 ± 1.2 18.4 ± 2.9 
18:4n-3 2.8 ± 0.2b 2.4 ± 0.2ab 2.4 ± 0.1a 2.9 ± 0.3 2.6 ± 0.0 2.6 ± 0.4 3.0 ± 0.1b 2.4 ± 0.1ab 1.1 ± 0.9a 2.9 ± 0.4 2.8 ± 0.2 2.8 ± 0.2 
20:3n-3 1.3 ± 0.0b 1.2 ± 0.0b 0.9 ± 0.1a 1.4 ± 0.0 1.3 ± 0.0 1.1 ± 0.2 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.1 0.8 ± 0.0 0.8 ± 0.0 0.7 ± 0.1 
20:4n-3 0.4 ± 0.0b 0.4 ± 0.0a 0.5 ± 0.0c 0.5 ± 0.0 0.4 ± 0.0 0.5 ± 0.0 1.0 ± 0.1 0.9 ± 0.1 1.0 ± 0.0 1.1 ± 0.1 1.0 ± 0.1 1.1 ± 0.0 
20:5n-3 (EPA) 6.7 ± 0.5b* 5.9 ± 0.1a* 8.0 ± 0.2c* 8.3 ± 0.7ab* 7.6 ± 0.3a* 9.5 ± 0.9b* 4.3 ± 0.6 3.8 ± 0.7 2.9 ± 2.0* 4.8 ± 0.7 4.7 ± 0.7 6.2 ± 0.4* 
22:5n-3 ND ND 0.4 ± 0.1 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.2 0.4 ± 0.1 0.3 ± 0.1 0.4 ± 0.2 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.4 
22:6n-3 (DHA) 3.4 ± 0.7a 3.3 ± 0.4a 10.6 ± 1.3b 4.2 ± 1.0 3.9 ± 1.0 8.4 ± 5.4 13.8 ± 4.9 10.9 ± 3.9 6.5 ± 3.2* 14.4 ± 5.6 13.0 ± 3.5 14.7 ± 3.2* 
Total n-3 30.6 ± 0.2b* 28.6 ± 1.2a* 35.0 ± 0.4c* 34.3 ± 0.3* 32.3 ± 1.4* 36.5 ± 2.6* 44.7 ± 3.1b 39.3 ± 4.1ab 31 ± 4.8a 45.7 ± 2.8 43.3 ± 3.2 44.4 ± 3.6 
DHA/EPA 0.5 ± 0.1a 0.6 ± 0.1a 1.4 ± 0.2b 0.5 ± 0.1 0.5 ± 0.1 0.9 ± 0.5 3.4 ± 0.8 3.1 ± 0.5 2.8 ± 0.9 2.9 ± 0.8 2.7 ± 0.4 2.4 ± 0.6 
DHA/EPA: docosahexaenoic and eicosapentaenoic fatty acid ratio; DW: dry weight; FA: fatty acids; ND: not detected; TL: total lipids. 
Figure 1. Total phosphorus contents in Artemia nauplii from Exp. 2 before (ENR 22 h) and after (ENR 24 h) the 
phospholipid source enrichment (“boosting”). Data represent means ± standard deviations (n = 3). * indicates a 
statistical difference between time samples within the same diet (paired t-test, T ≤ 0.05). Superscripts denote 
significant differences between treatments (one-way ANOVA and Tukey’s post-hoc test, P < 0.05). MG: Larviva 
Multigain; SL: soya lecithin; ML: marine lecithin. 
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